Skip to main content
Premium Trial:

Request an Annual Quote

Genome Canada Awards AniGenics $17.5M to Study Animal Pathogenesis

NEW YORK, May 24 - Genome Canada has awarded animal-genomics company AniGenics C$27 million, or $17.5 million, to identify host factors that influence disease resistance to certain animal-borne pathogens, the firm said today.

 

AniGenics, based in Chicago, will perform the research with a consortium that includes the Veterinary Infectious Disease Organization, the University Saskatchewan, and the University of British Columbia, according to the company.

 

Click here for more information.